Buprenorphine

Cancer Journal: A table of contents

I am a psychologist, a health services researcher, and a contributor to The Incidental Economist. The Cancer Journal reports my experiences as a cancer patient in the COVID pandemic. “I have serious news.” My day and night in the Emergency Department on July 2nd and […]

Covid Vaccine Month of Action

The Biden administration has announced a new a goal when it comes to Covid-19 vaccinations in the US: It aims for at least 70% of Americans to receive at least one dose by July 4th. The current administration has announced a plan and lots of […]

The Proposed Hospital Mega-Merger in Rhode Island Shouldn’t Happen

The two largest hospital systems in Rhode Island, Lifespan and Care New England (CNE), submitted an application to the state in April to form a new health system in partnership with Brown University.* In spite of proponents’ claims to the contrary, this mega-merger would likely […]

Buprenorphine Regulations and Better Treatment of Addiction

We face a lot of obstacles on the road to ending the opioid crisis, and one of them revolves around access to evidence-based addiction treatments. The X-waiver, a waiver physicians must obtain to prescribe the partial opioid agonist Buprenorphine, is one of them. New regulations […]